In this webinar, Dr. Thomas LeBlanc from Duke University Hospital discusses AML - how the diagnosis and treatment decisions impact patients. He provides a basic overview of AML and current treatments.
Rare blood cancer and bone marrow failure diseases are often difficult to diagnose and even harder to explain. AAMDSIF brings international experts to your computer, tablet or smartphone using language that is easy to understand in a convenient one hour format. We have hundreds of webinars available for you to watch at any time you want!
Support for the 2023 AAMDSIF Webinar series is generously provided by Amgen, Apellis Pharmaceuticals, Merck & Co., and Taiho Oncology.
|Tue, 11/14/2023 - 2:00pm (EST)||Caregivers - Take Care but HOW????|
|Tue, 11/21/2023 - 1:00pm (EST)||CCUS and MDS|
|Wed, 11/22/2023 - 11:00am (EST)||Cytopenia Management of Low Risk MDS|
|Wed, 11/29/2023 - 2:00pm (EST)||Living with PNH: Navigating Finances and Insurance|
|Mon, 12/11/2023 - 12:00pm (EST)||Integrative Medicine|
|Tue, 12/12/2023 - 2:00pm (EST)||Caregiver Panel - Let's Talk About Caring for Others|
Dr. Kasiani Myers of The Cancer and Blood Diseases Institute in Cincinnati, OH discusses the causes, diagnosis, and treatment of aplastic anemia and PNH. She will also discuss the relationship between aplastic anemia and PNH and how the dual diagnosis is treated.
In this webinar, Dr. Matt Kalaycio explains what is a bone marrow transplant and the risk and benefits of a transplant for MDS patients. Patients will be able to use the information learned in this webinar to have a discussion with their treating physician if a transplant is right for them.
During this program, Dr. Bhumika Patel and Dr. Jaroslaw Maciejewski from Taussig Cancer Institute discuss research reported over the past year on the biology and treatment of aplastic anemia and PNH. These studies were presented at the American Society of Hematology (ASH) 2018 meeting in San Diego, CA. Research findings are explained along with the potential impact of this research on understanding and treating aplastic anemia and PNH.
Dr Navada explains how healthcare professionals diagnosis and treat the overlapping conditions of aplastic anemia and MDS, outlining the decisionmaking process and key factors relevant to effective treatment.
This webinar explains how myeloid malignancies form in plain language for patients and families.
This webinar provides the viewer with a basic understanding of myeloproliferative neoplasms (MPNs) as well as a review of how MPNs overlap with other bone marrow failure diseases, especially MDS.
This webinar discusses the diagnosis and treatment options for pedaitric AML patients and their families.
Dr Malone explains the key issues for transplant patients during the first 100 days, focusing on Acute GVHD (graft-versus-host-disease).